• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Meta-analysis of the efficacy and safety of Shenkang injection combined with Western medicine in the treatment of chronic glomerulonephritis

    2022-12-03 02:09:30YangLiuYueJiZiXuanZhaoLuXuanGuoJinLinRongXinZhengGuanRanWangJinHuaSiXinYuanZhangNaHaoHongTaoYang
    Clinical Research Communications 2022年4期
    關(guān)鍵詞:腎康慢性腎炎血尿

    Yang Liu ,Yue Ji ,Zi-Xuan Zhao ,Lu-Xuan Guo ,Jin Lin ,Rong-Xin Zheng ,Guan-Ran Wang,Jin-Hua Si,Xin-Yuan Zhang,Na Hao*,Hong-Tao Yang*

    1Nephrology Department,First Teaching Hospital of Tianjin University of Traditional Chinese Medicine,Tianjin 300381,China.2National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion,Tianjin 300381,China.3School of Integrative Medicine,Tianjin University of Traditional Chinese Medicine,Tianjin 301617,China.4Psychosomatic Department,First Teaching Hospital of Tianjin University of Traditional Chinese Medicine,Tianjin 300381,China.

    Abstract Objective:The purpose of the research was to systematically evaluate the clinical efficacy and safety of Shenkang injection combined with Western medicine in treating chronic glomerulonephritis.Methods:Randomized controlled trials of Shenkang Injection combined with Western medicine in treating CGN were obtained from 8 Science databases including China National Knowledge Infrastructure (CNKI),China Biomedical Database(SinMed),Weipu Database (VIP),Wanfang Database (Wanfang),PubMed,The Cochrane Library,Embase,Web of Science from establishment to June 2022.Two researchers screened literature and extracted useful data according to inclusion and exclusion criteria,and used RevMan 5.3 and STATA SE 14.0 software to perform meta-analysis.Results:1,214 patients were included in 15 studies,with 607 in treatment group and 607 in control group.The results of meta-analysis showed that the treatment group could improve the clinical effective rate[RR=1.33,95%CI(1.25,1.40),P<0.00001],reduce serum creatinine[MD=-31.28,95% CI (-42.90,-19.66), P<0.00001],blood urea nitrogen [MD=-2.26,95%CI(-3.08,-1.44), P<0.00001],24-hour urine protein quantification [MD=-0.37,95% CI(-0.49,-0.25), P<0.00001],tumor necrosis factor -α [MD=-7.93,95% CI(-10.56,-5.30),P<0.00001],systolic blood pressure[MD=-10.81,95%CI(-13.66,-7.96),P<0.00001]and diastolic blood pressure [MD=-7.36,95% CI (-9.34,-5.38), P<0.00001].Conclusion:Shenkang injection combined with Western medicine can enhance the clinical effective rate of CGN and reduce the levels of serum creatinine,blood urea nitrogen,24-hour urine protein quantification,tumor necrosis factor-α,systolic blood and diastolic blood pressure.However,due to the low quality of literature,the conclusion still needs to be supported by more multi-center,large-sample studies with rigorous design and standardized implementation.

    Keywords: Shenkang injection;chronic glomerulonephritis;curative effect;randomized controlled trials;meta-analysis

    Introduction

    Chronic glomerulonephritis (CGN),a representative chronic kidney disease (CKD),is characterized by haematuria,proteinuria,edema,and hypertension [1].In 2017,average prevalence of CKD was globally 9.1%,an increase of 29% compared with 1990 [2].CKD affects about 10% of adults worldwide,causing 1.2 million deaths per year [3].CKD,by 2040,is predicted to be the fifth leading cause of death worldwide [4].As renal function declines,patients will have different degrees of heart and lung function decline,malnutrition,psychological function and cognitive impairment,seriously affecting patients' quality of life [5,6].The studies have shown [7] that autoimmunity,infection and inflammation affect development of CGN,but specific pathogenesis and molecular mechanism of CGN remain unclear [8].Currently,antihypertensive,anticoagulant,hormonal and cytotoxic drugs are commonly used in treating CGN to alleviate severe symptoms and slow down the occurrence of renal failure.However,these treatment schemes also have disadvantages in efficacy,cost and side effects[9].More and more studies have verified the curative effect of Traditional Chinese medicine in the treatment of CGN [10,11].Shenkang injection (SKI) contains Dahuang (Rheum palmatum),Huangqi (Astragalus membranaceus),Danshen (Salvia miltiorrhiza) and Honghua (Carthamus tinctorius),which has the functions of relaxing bowel and lowering turbidity,it can invigorate qi and promote blood circulation,mainly applied in treating chronic renal failure [12-14].SKI can clear free radicals in the body,correct lipid metabolism disorder,delay the damage of renal function,inhibit protein decomposition,inhibit water and sodium retention,etc [15].SKI combined with Western medicine can significantly reduce the level of inflammatory factors such as interleukin-6 and tumor necrosis factor-α in patients,and improve the oxidative stress and inflammatory state of patients [16].Recent clinical observations have shown that SKI can significantly reduce the levels of serum creatinine,blood urea nitrogen and 24-hour urine protein quantification in CGN patients to improve clinical effective rate [17,18].At present,more and more clinical studies confirming positive effect of SKI on CGN patients have indicated clinical symptoms' improvement of CGN patients.However,there are differences in protocol design,evaluation criteria and observation indicators among different studies,and scientific evidence-based medicine methods are needed to evaluate its efficacy.Our study systematically gathered the randomized controlled trials (RCTs) of SKI combining Western medicine in treating CGN,so as to assist clinical practice in providing evidence.

    Methods

    This research was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) and is registered in PROSPERO (CRD42022297770).

    Search strategy

    We gathered RCTs of SKI combining Western medicine in treating CGN from 8 Science databases including CNKI,VIP,Wanfang,SinoMed,PubMed,Embase,the Cochrane Library,and Web of Science from establishment to June 2022.Chinese search terms were as follows: 慢性腎炎,慢性腎小球腎炎,慢性原發(fā)性腎小球疾病,腎康注射液,腎康注射劑.English search terms were as follows: Shenkang injection,chronic nephritis,chronic glomerulonephritis,etc.Keywords combined with free words were used to search.Taking CNKI and PubMed as examples,their specific search strategies were as follows.The two researchers (Yang Liu and Yue Ji) extracted data from the included literature at the same time,including the authors,publication year,patient age,intervention measures,control measures,outcome indicators,course of disease and course of treatment.We used Excel spreadsheet tools to carefully record and check each other,and the third researcher (Na Hao) would help solve any differences.

    Inclusion and exclusion criteria

    Inclusion criteria.(1) Study types: RCTs of SKI combined with Western medicine in the treatment of CGN.(2) Study subjects:clinically diagnosed CGN patients presented with hematuria,proteinuria,edema,and hypertension.Regardless of race,sex,age and nationality,the intra-group basis linearity was good.Diagnosis basis:Guidelines for the diagnosis and treatment of chronic glomerulonephritis[19],Internal Medicine[20],Diagnosis,Syndrome differentiation and curative effect evaluation of Chronic glomerulonephritis (trial program)[21],Nephrology[22].(3) Interventions: The control group: either treatment of alprostadil injection,ACEI or ARB (no limits on drug dosage,daily use frequency,manufacturer,etc.).The treatment group was additionally given SKI (no limits on drug dose,daily drip frequency,manufacturer,etc.),and other treatments were the same as the control group.(4) Outcome indicators: Main outcome indicators:Clinical effective rate (referring toGuiding Principles for Clinical Research of New Chinese Medicine[23],Diagnosis,Syndrome differentiation and curative effect evaluation of Chronic glomerulonephritis(trial program)[24] andSummary of discussion on diagnosis and treatment of renal disease and efficacy criteria[25]),clinical efficacy rate=The number of significant and effective cases/total number of cases× 100%.Secondary outcome indicators: serum creatinine(Scr),blood urea nitrogen (BUN),24-hour urine protein quantification(24h-UP),tumor necrosis factor-α (TNF-α),systolic blood pressure(SBP)and diastolic blood pressure(DBP).Clinical studies must include one or more of these outcomes.

    Exclusion criteria.(1) Studies did not meet the correct diagnostic criteria;(2) Studies using SKI combined with other traditional Chinese medicine therapies;(3) Studies that only have abstracts and the original data cannot be fully obtained;(4)Duplicate published studies;(5) review,cases of famous doctors,case reports,animal experiments and other non-clinical RCT studies.

    Study selection and data extraction

    Two evaluators (Yang Liu and Yue Ji) independently screened the literature according to the inclusion and exclusion criteria,excluded obviously irrelevant literature and cross-checked the results.In case of any disagreement,a third party (Hong-Tao Yang) participated in the discussion and decided.The software of NoteExpress was used to delete duplicate literature,and further exclude non RCTs studies such as reviews,case reports and animal experiments by reading the title and abstract of the literature.Finally,we read the full text of the literature,reasonably screen the literature according to the inclusion and exclusion criteria,and determine the final included literature.

    Risk of bias analyses

    Two evaluators(Yang Liu and Yue Ji)assessed the literature quality of the incorporated research according to the Cochrane manual 5.1[26],including the generation of random sequences,allocation concealment,blind measures,the integrity of outcome indicators,selective reports,and other biases.

    Application of statistical methods

    Revman 5.3 software was used for analysis.The relative risk(RR) and mean difference (MD) were used as efficacy indicators for counting data and continuity variables.If the numerical units were inconsistent,the standardized mean difference (SMD) was used for analysis.The Chi-square test was used to test the heterogeneity of results.IfP>0.10,I2<50%,it was considered that the heterogeneity among studies was small,and the fixed effect model was used.IfP≤0.10,I2≥50%,it was considered that there was great heterogeneity among studies,and the random effect model was used,and the source of heterogeneity should be further evaluated through subgroup analysis or sensitivity analysis.We Used the random effect model after excluding significant clinical and methodological heterogeneity [27].STATA SE 14.0 software was used for sensitivity analysis to explore whether a single study impacted on the total effect size of outcome indicators.The funnel plot was used to detect publication bias (n>10) for the major outcome indicators,and publication bias was quantitatively detected by Begg's test and Egger's Test[28,29].IfP<0.05,publication bias was indicated in the outcome indicators,and publication bias was corrected by trim and fill method[30,31].

    Results

    Study characteristics

    According to the established retrieval formula,116 pieces of related literature were retrieved,55 duplicate literature were removed.Read the title and abstract further and exclude 10 articles that do not meet the inclusion exclusion criteria.Through reading the full text,36 studies that did not meet the inclusion and exclusion criteria were excluded.Finally,15 studies [17,18,32-44] were included,all of which were Chinese literature with publication years from 2017 to 2021 (Figure 1).

    The key features included in the studies are shown in Table 1.15 RCTs were included,including 1,214 patients,607 in the treatment group and 607 in the control group.Sample sizes for individual studies ranged from 54 to 120 people,and the therapy course was 12 to 120 days.The treatment group was treated with Shenkang injection combined with Western medicine,and the control group was treated with Western medicine.(Tables 1 and 2).

    Table 1 Included studies'characteristics.

    Bias's risk analyses

    We used the Cochrane Bias risk Assessment tool to assess bias's risk in the 15 RCTs.In terms of random sequence generation,9 literature[17,18,32,34,37,38,40,43,44] were grouped by random number table method and evaluated as "low risk".6 literature [33,35,36,39,41,42] neglected the randomization method and got an "unclear".In terms of allocation concealment and blinding,only one literature[35]proposed the "double-blind" scheme,which was evaluated as "low risk",and the rest neglected allocation concealment and blinding implementation,which were evaluated as "unclear".In terms of outcome data integrity,all the included studies had good integrity with no case loss.In terms of selective reporting,none of the included studies were published selectively.Other biases were not mentioned in any of the included literature (Figure 2).

    Meta-analysis results

    Clinical effective rate.14 studies [17,18,32-35,37-44] reported clinical effective rate,1,160 patients were enrolled,with 580 in treatment group and 580 in control group.The results showed that there was low heterogeneity among studies (P=0.10,I2=35%),so we used the fixed effect model for the meta-analysis.The results indicated significantly higher clinical effective rate of the treatment group than the control group with statistically significant difference[RR=1.33,95% CI(1.25,1.40),P<0.00001) (Figure 3).

    Figure 1 Literature retrieval and screening process

    Serum creatinine.10 studies[17,18,32-35,37,40,43,44]reported levels of Scr before and after treatment,including a total of 834 patients,with 417 in the treatment group and 417 in the control group.The adopt random effect model was used due to the large heterogeneity among studies [P<0.00001,I2=97%].The results showed that the treatment group had more advantages in reducing the level of Scr [MD=-31.28,95% CI (-42.90,-19.66),P<0.00001].It was proved that SKI combining western medicine had more advantages in reducing the level of Scr than conventional western medicine alone (Figure 4).

    We explored the source of heterogeneity through subgroup analysis.The results showed that the heterogeneity mainly came from the difference of treatment measures in the itreatment group.Conduct subgroup analysis basing different western drugs combined in the treatment group,which were divided into SKI+Alprostadil injection[18,33,35,40],SKI+Valsartan Tablets [17,34,44] and SKI +Benazepril Tablets [32,37,43].The results of heterogeneity test showed that the heterogeneity between SKI+Alprostadil injection was significantly reduced [P=0.06,I2=60%],no heterogeneity between SKI+Valsartan Tablets was seen [P=0.40,I2=0%],and the heterogeneity between SKI+Benazepril Tablets was still very high[P< 0.00001,I2=94%].The random effect model analysis indicated: SKI+Alprostadil injection [MD=-43.07,95% CI (-49.36,-36.78),P<0.00001],SKI+Valsartan Tablets[MD=-6.97,95%CI(-9.75,-4.18),P<0.00001],SKI+Benazepril Tablets[MD=-40.53,95% CI(-54.38,-26.68),P<0.00001].The subgroup analysis results confirmed statistically significant difference between treatment and control groups (P<0.05) (Figure 5).

    Blood urea nitrogen.10 studies [17,18,32-35,37,40,43,44]reported changes in the level of BUN before and after treatment,involving a total of 834 patients,with 417 in treatment group and 417 in control group.We used the random effect model for analysis due to significant heterogeneity among studies [P<0.00001,I2=95%].The results of meta-analysis showed that combined SKI had more obvious advantages in reducing the level of BUN on thr basis of Western medicine alone [MD=-2.26,95% CI (-3.08,-1.44),P<0.00001] (Figure 6).

    We analyzed the treatment group combined with different kinds of Western medicine to identify the source of heterogeneity.The heterogeneity test results indicated: there was no heterogeneity of SKI+Alprostadil injection [18,33,35,40] [P=0.45,I2=0%],the heterogeneity of SKI+Valsartan Tablets [17,34,44] was also significantly reduced [P=0.08,I2=60%],there was no heterogeneity among SKI+Benazepril Tablets [32,37,43] [P=0.94,I2=0%],the adopt random effect model for analysis:SKI+Alprostadil injection [MD=-2.11,95% CI (-2.38,-1.83),P<0.00001],SKI+Valsartan Tablets [MD=-0.66,95% CI (-1.09,-0.22),P=0.003],SKI+Benazepril Tablets [MD=-4.17,95% CI(-4.61,-3.72),P<0.00001].It shows that there were significant differences between the treatment group and the control group in reducing the level of BUN (P<0.05) (Figure 7).

    24-hour urine protein quantification.11 studies[17,18,32-34,36,37,41-44] reported the changes of the level of 24h-UP before and after SKI combining Western medicine in treating CGN,involving 878 patients,with 439 in treatment group and 439 in control group.The significant heterogeneity among the studies was still high after subgroup analysis based on different interventions and treatment courses in the treatment group.After eliminating individual studies one by one,the heterogeneity within the group has scarcely altered,and the confidence intervals are located on the left side of the invalid line of the forest map,demonstrating that the heterogeneity between studies has no impact on the results,so we adopted the random effect model,which showed that the treatment group was more advantageous in reducing the level of 24h-UP [MD=-0.37,95% CI(-0.49,-0.25),P<0.00001] (Figure 8).

    Tumor necrosis factor-α.3 studies [38,40,44] reported inter-group the level of TNF-α,including 282 patients totally,with 141 in treatment group and 141 in control group.We used the random effect model due to significant heterogeneity between studies [P=0.08,I2=60%].The meta-analysis results showed that combined SKI had more obvious advantages in reducing the level of TNF-α on the basis of western medicine alone [MD=-7.93,95% CI (-10.56,-5.30),P<0.00001].We observed significant reduction of heterogeneity after excluding Rui Liu [40] [P=0.31,I2=3%].Considering that the heterogeneity might be caused by various interventions and treatment courses,we adopted the fixed effect model,which presented statistically significant reduction in TNF-α between treatment and control group [MD=-6.81,95% CI (-8.49,-5.12),P<0.00001](Figure 9).

    Blood pressure.2 studies [32,43] reported the changes of SBP and DBP between groups,with 97 cases in the treatment group and 97 cases in the control group.The intra group heterogeneity of the two outcome indicators was low [P=1.00,I2=0%].The results of meta-analysis showed that the treatment group was significantly better than the control group in reducing the levels of SBP and DBP[MDSBP=-10.81,95%CI(-13.66,-7.96),P<0.00001],[MDDBP=-7.36,95% CI(-9.34,-5.38),P<0.00001] (Figures 10 and 11).

    Adverse reactions rate.3 studies [18,32,34] reported the occurrence of adverse reactions,involving 266 patients totally,with 133 in treatment group and 133 in control group.The results showed that there was low heterogeneity among studies [P=0.46,I2=0%].We used the fixed effect model due to low heterogeneity between studies [RR=0.46,95% CI (0.18,1.18),P=0.11)],and significant difference was not seen in adverse reactions incidence between treatment group and control group (P>0.05) (Figure 12).

    Sensitive analysis

    We used STATA SE 14.0 software to conduct sensitivity analysis on clinical effective rate,Scr,BUN and 24h-UP respectively to test results'stability,and the results were shown below.The combined effect size was still within 95% CI of the total effect size after removing one by one,indicating that the results were stable and reliable(Supplementary Figure S1-S4).

    Publication bias evaluation of clinical effective rate

    Qualitative detection of funnel plot.The software STATA SE14.0 was used to draw funnel plot for publication bias analysis of clinical effective rate,with effect size(logrr) as the horizontal coordinate and standard error of effect size (selogrr) as the vertical coordinate.Results showed that most of the scattered points were evenly distributed within the 95% confidence interval,and only a few scattered points were distributed outside the interval.The funnel plot showed obvious asymmetry,informing possibility of publication bias risk(Figure 13).

    Quantitative detection of Begg map and Egger's map.In order to clarify whether there was publication bias in clinical effective rate,Begg rank correlation test and Egger 's linear regression method were used for quantitative detection.Begg'test results showed that the Pr >|z|=0.001<0.05,Egger's test results showed that theP>|t|=0.000 <0.05,indicating significant publication bias in clinical effective rate results.Metatrim module in STATA SE 14.0 was used to identify and correct the publication bias of clinical effective rate,and the results were shown as: before using the trim and filling method,fixed effect model [RR=0.240,95% CI (0.186,0.294),P=0.000];random effect model [RR=0.254,95% CI (0.189,0.320),P=0.000].After 6 iterations of Linear method,6 studies were found to be missing.After including the missing studies,results were: after using the trim and filling method,fixed effect model [RR=0.184,95% CI(0.136,0.232),P=0.000];random effect model [RR=0.188,95%CI (0.133,0.263),P=0.000].The statistically significant 95% CI (P<0.05) of the fixed and the random effect model before and after using the trim and filling method indicated relatively robust clinical effective rate meta-analysis results,and the potential publication bias had little influence on it (Supplementary Figure S5-S7).

    Figure 2 Bias's risk summary

    Figure 3 Forest map of clinical effective rate meta-analysis

    Figure 4 Forest map of Scr meta-analysis

    Figure 5 Forest map of Scr subgroup meta-analysis of treatment group combining different Western drugs

    Figure 6 Forest map of BUN meta-analysis

    Figure 7 Forest map of BUN subgroup meta-analysis of treatment group combined with different Western drugs

    Figure 8 Forest map of 24h-UP meta-analysis

    Figure 9 Forest map of TNF-α meta-analysis

    Figure 10 Forest map of SBP meta-analysis

    Figure 11 Forest map of DBP meta-analysis

    Figure 12 Meta-analysis of adverse reactions incidence

    Figure 13 Funnel plot of clinical effective rate

    Discussion

    In Traditional Chinese Medicine,CGN belongs to the categories of"hematuria (血尿)","low back pain (腰痛)","edema (水腫)" and"fatigue (虛勞)" [45,46],and the pathogenesis is mainly attributed to spleen and kidney deficiency and the invasion of evil Qi,leading to symptoms of hematuria,edema and lumbago [47].Clinically,strengthening spleen and kidney,invigorating qi and promoting blood circulation are the main treatment methods to strengthen vital Qi and remove pathogens [48].Dahuang is the sovereign drug in SKI and has the effect of relaxing bowel and lowering turbidity,can promote blood circulation and remove dampness;Huangqi,as the minister drug,has the function of ascending the clear and descending the turbid,tonifying Qi and dispersing blood stasis;Danshen and Honghua,as the assistant drug,can help the sovereign drug promote blood circulation to remove blood stasis.The whole is skilled at invigorating Qi and activating blood circulation,relaxing bowel and lowering turbidity[49,50].Modern pharmacological studies have found that Dahuang contains anthraquinone derivatives,polysaccharides and other chemical components,which can reduce angiotensin converting enzyme production,improve the high metabolic status of residual kidney,increase glomerular filtration rate,reduce glomerular sclerosis and inhibit inflammation [51,52];Huangqi can reduce interleukin-6 and TNF-α [53,54] to regulate immune function and exert anti-inflammatory effect;Safflower yellow pigment,the main component of Honghua [55] can inhibit platelet aggregation and activation and prevent blood coagulation;Salvianolate [56],the main active component of Danshen can delay kidney injury by regulating transforming growth factor β1 (TGF-β1) and Monocyte Chemoattractant Protein 1 (MCP-1),and its water-soluble component[57]can inhibit or reduce lipid peroxidation by scavenging superoxide anions and hydroxyl radicals.In conclusion,SKI can be anti-inflammatory and anticoagulant,reduce platelet aggregation,promote the repair of kidney tissue,protect residual renal function,reduce the risk of transformation from CGN to chronic renal failure,and reduce the occurrence of various complications.

    In this study,the meta-analysis was conducted on 15 RCTs,and the results indicated better clinical effective rate of SKI combing conventional Western medicine than Western medicine alone.Combining SKI with modern medicine can better reduce the levels of Scr,BUN,24h-UP,TNF-α and BP.Due to the large heterogeneity after the combination of outcome indicators,considering the risk of bias caused by simple combination,subgroup analyses were conducted based on various Western medicine and different treatment course between groups,and the results all confirmed the effectiveness of SKI.In terms of adverse reactions,one case of nausea occurred in the treatment group of Ying Sun[34];Ping-Hua Li[32]reported 1 case of rash and 1 pruritus;Jin-Li Dong [18] reported 2 vascular pain and 1 local redness,and the three control groups also suffered adverse reactions of varying degrees.No statistical significance of adverse reaction incidence was seen between the treatment and the control group (P>0.05),indicating that SKI may not reduce adverse reactions occurrence.According to the retrospective analysis of 19 patients with SKI-induced adverse reaction by De-Long Duo [58],63.16%of the patients had adverse reactions after 30 min intravenous infusions,among which the top three adverse reactions were nervous system damage,skin and accessory damage,and systemic damage.Those adverse reactions may be due to the inclusion of polysaccharides,proteins and other complex macromolecular antigens,easy to produce allergic reactions [59].Some of the reasons may be due to irregular infusion and individual differences,such as unreasonable dosage and duration,drug mixing,and age differences[60].As for the safety of SKI,more clinical evidence is still needed to confirm it since we only included few literature.

    This study has some limitations: (1) the randomization of some studies was unclear,and few studies have used blinding and allocation hiding;(2) the included subjects were all from China,so there may be publication bias of specific population;(3) there were different diagnostic criteria in the diagnosis of CGN,and most of the literature did not explain the diagnostic criteria of CGN;(4) in the evaluation criteria of clinical effective rate,the accuracy of outcome indicators may be affected because the evaluation criteria have not been unified.

    Conclusion

    SKI combined with Modern medicine can improve the clinical effective rate of CGN and reduce the levels of Scr,BUN,24H-UP,TNF-α,SBP and DBP.However,due to the low quality of literature,the conclusion still needs to be supported by more multi-center,large-sample studies with rigorous design and standardized implementation.

    猜你喜歡
    腎康慢性腎炎血尿
    血尿的夢(mèng)魘 橫紋肌溶解
    中國自行車(2018年8期)2018-09-26 06:53:34
    出現(xiàn)血尿必須上醫(yī)院檢查
    人人健康(2016年21期)2016-11-05 11:05:31
    海昆腎喜膠囊聯(lián)合腎康注射液治療慢性腎衰42例療效觀察
    綜合護(hù)理在慢性腎炎合并抑郁患者中的應(yīng)用觀察
    六味地黃湯加減治療慢性腎炎蛋白尿258例
    蛋白尿方聯(lián)合科素亞治療慢性腎炎臨床分析
    34 例腎康注射液不良反應(yīng)報(bào)告
    腎康注射液聯(lián)合西醫(yī)治療慢性腎衰竭療效及對(duì)脂代謝紊亂的影響
    腎康注射液不良反應(yīng)特征分析
    尿TGF-β1檢測(cè)在診斷慢性腎炎中的臨床應(yīng)用
    亚洲全国av大片| 他把我摸到了高潮在线观看| 国内精品久久久久精免费| 性欧美人与动物交配| 别揉我奶头~嗯~啊~动态视频| 中国美女看黄片| 欧美日韩中文字幕国产精品一区二区三区 | 免费看美女性在线毛片视频| 亚洲熟妇中文字幕五十中出| 精品国产美女av久久久久小说| 国产精品久久久人人做人人爽| 中文字幕久久专区| 99在线视频只有这里精品首页| 亚洲七黄色美女视频| 丝袜美腿诱惑在线| av有码第一页| 久久久久久国产a免费观看| 久久精品影院6| 亚洲av成人av| 亚洲第一青青草原| 91麻豆精品激情在线观看国产| 久久婷婷人人爽人人干人人爱 | 男人操女人黄网站| 香蕉国产在线看| av福利片在线| 中文字幕人妻熟女乱码| 在线观看免费午夜福利视频| 麻豆国产av国片精品| 国产极品粉嫩免费观看在线| 国产亚洲av嫩草精品影院| 狠狠狠狠99中文字幕| 久久婷婷人人爽人人干人人爱 | 亚洲黑人精品在线| 两个人视频免费观看高清| 亚洲国产精品成人综合色| 色精品久久人妻99蜜桃| 免费搜索国产男女视频| 18美女黄网站色大片免费观看| 啪啪无遮挡十八禁网站| 麻豆av在线久日| 一边摸一边抽搐一进一小说| 色精品久久人妻99蜜桃| 大香蕉久久成人网| 麻豆av在线久日| 18禁裸乳无遮挡免费网站照片 | 18禁国产床啪视频网站| 88av欧美| 久久香蕉国产精品| av在线天堂中文字幕| 51午夜福利影视在线观看| av网站免费在线观看视频| 日本 欧美在线| 在线观看午夜福利视频| 母亲3免费完整高清在线观看| 18禁美女被吸乳视频| av超薄肉色丝袜交足视频| 午夜亚洲福利在线播放| 天天添夜夜摸| 欧美激情极品国产一区二区三区| 日韩欧美一区视频在线观看| 久久国产精品男人的天堂亚洲| 免费少妇av软件| 亚洲少妇的诱惑av| 久久久久久人人人人人| 不卡一级毛片| 欧美一区二区精品小视频在线| 精品一区二区三区视频在线观看免费| 亚洲电影在线观看av| 国产成人欧美| 国产野战对白在线观看| 亚洲电影在线观看av| 久久国产精品影院| 一二三四在线观看免费中文在| 一边摸一边做爽爽视频免费| 精品国产超薄肉色丝袜足j| 欧美日韩黄片免| 国产精品一区二区免费欧美| 老鸭窝网址在线观看| 在线观看一区二区三区| 欧美激情久久久久久爽电影 | 欧美国产精品va在线观看不卡| 欧美日韩一级在线毛片| 国产av一区二区精品久久| 妹子高潮喷水视频| 搞女人的毛片| 激情在线观看视频在线高清| 妹子高潮喷水视频| 亚洲精品一区av在线观看| 久久婷婷成人综合色麻豆| 最好的美女福利视频网| 一级a爱片免费观看的视频| 午夜免费观看网址| 国产一区二区激情短视频| 亚洲欧美一区二区三区黑人| 国产成人精品久久二区二区91| 亚洲国产欧美一区二区综合| 国产高清有码在线观看视频 | 50天的宝宝边吃奶边哭怎么回事| 啦啦啦观看免费观看视频高清 | 黄色女人牲交| xxx96com| 精品久久久久久久人妻蜜臀av | 91成人精品电影| 亚洲全国av大片| 国产精品久久久久久亚洲av鲁大| 在线观看一区二区三区| 深夜精品福利| 国产精品爽爽va在线观看网站 | 亚洲国产毛片av蜜桃av| 日韩 欧美 亚洲 中文字幕| 国产成人系列免费观看| 欧美午夜高清在线| 国产精品九九99| 成人免费观看视频高清| 国产成人精品久久二区二区91| 男人的好看免费观看在线视频 | 亚洲精品国产区一区二| 色哟哟哟哟哟哟| 涩涩av久久男人的天堂| 欧美午夜高清在线| 黑丝袜美女国产一区| 一级片免费观看大全| 嫁个100分男人电影在线观看| 99riav亚洲国产免费| 久99久视频精品免费| 欧美中文日本在线观看视频| 久久人人爽av亚洲精品天堂| 啦啦啦韩国在线观看视频| 搞女人的毛片| 日韩中文字幕欧美一区二区| 国产欧美日韩一区二区三区在线| 亚洲成人精品中文字幕电影| 久久精品国产亚洲av香蕉五月| 亚洲精品美女久久久久99蜜臀| 亚洲性夜色夜夜综合| 欧美日韩亚洲综合一区二区三区_| cao死你这个sao货| 51午夜福利影视在线观看| 久久午夜亚洲精品久久| 两人在一起打扑克的视频| 老司机福利观看| 脱女人内裤的视频| 日韩国内少妇激情av| 久热爱精品视频在线9| 亚洲专区中文字幕在线| 99re在线观看精品视频| 久久久久久大精品| 夜夜爽天天搞| 18禁黄网站禁片午夜丰满| 亚洲av电影不卡..在线观看| 亚洲色图综合在线观看| 成人永久免费在线观看视频| 国产99白浆流出| 99re在线观看精品视频| 国产精品一区二区三区四区久久 | 国产精品影院久久| 啦啦啦免费观看视频1| 日本 av在线| videosex国产| 亚洲av熟女| 非洲黑人性xxxx精品又粗又长| 日韩欧美国产在线观看| 一本综合久久免费| 男人舔女人的私密视频| 又黄又粗又硬又大视频| 久久精品国产综合久久久| 欧美国产精品va在线观看不卡| 动漫黄色视频在线观看| 国产一级毛片七仙女欲春2 | 女人高潮潮喷娇喘18禁视频| 男女做爰动态图高潮gif福利片 | 欧美日韩一级在线毛片| 国产精品永久免费网站| 咕卡用的链子| 老汉色∧v一级毛片| 日韩 欧美 亚洲 中文字幕| 在线天堂中文资源库| 国产成人精品久久二区二区91| 国产麻豆69| 久久人人爽av亚洲精品天堂| 少妇熟女aⅴ在线视频| 大型黄色视频在线免费观看| 久久天堂一区二区三区四区| 视频区欧美日本亚洲| 麻豆av在线久日| 国产精品秋霞免费鲁丝片| 在线播放国产精品三级| 欧美乱色亚洲激情| 18禁观看日本| 亚洲第一av免费看| 国产成年人精品一区二区| 亚洲一码二码三码区别大吗| 美女 人体艺术 gogo| 黄色a级毛片大全视频| netflix在线观看网站| 国产亚洲精品久久久久久毛片| 亚洲成人精品中文字幕电影| 久久久水蜜桃国产精品网| 99国产精品一区二区蜜桃av| 精品无人区乱码1区二区| 久久午夜综合久久蜜桃| 不卡av一区二区三区| 亚洲全国av大片| 神马国产精品三级电影在线观看 | 99riav亚洲国产免费| 制服诱惑二区| 日本三级黄在线观看| 一本大道久久a久久精品| 91字幕亚洲| 亚洲成av片中文字幕在线观看| 欧美成人一区二区免费高清观看 | 欧美成人免费av一区二区三区| 久久久久精品国产欧美久久久| 亚洲av片天天在线观看| 麻豆久久精品国产亚洲av| 欧美黑人精品巨大| 免费观看人在逋| bbb黄色大片| 中文字幕最新亚洲高清| www日本在线高清视频| 一区在线观看完整版| 夜夜爽天天搞| 国产精华一区二区三区| svipshipincom国产片| 好看av亚洲va欧美ⅴa在| ponron亚洲| 亚洲欧美日韩无卡精品| 精品久久久久久久毛片微露脸| 欧美人与性动交α欧美精品济南到| 女人被狂操c到高潮| 真人做人爱边吃奶动态| 两性午夜刺激爽爽歪歪视频在线观看 | 亚洲精品国产色婷婷电影| www日本在线高清视频| 亚洲精品一区av在线观看| 女性生殖器流出的白浆| 欧洲精品卡2卡3卡4卡5卡区| 91精品国产国语对白视频| 国产精品亚洲一级av第二区| 欧美一区二区精品小视频在线| 亚洲av成人av| 亚洲精品久久国产高清桃花| 成熟少妇高潮喷水视频| 9191精品国产免费久久| 不卡一级毛片| 久久天堂一区二区三区四区| 人成视频在线观看免费观看| 免费不卡黄色视频| 一级毛片高清免费大全| 12—13女人毛片做爰片一| 亚洲成人国产一区在线观看| 制服丝袜大香蕉在线| 国产成人一区二区三区免费视频网站| 国内精品久久久久精免费| 亚洲人成网站在线播放欧美日韩| 亚洲国产毛片av蜜桃av| 久久香蕉国产精品| 男人操女人黄网站| 国产成人av激情在线播放| 动漫黄色视频在线观看| 婷婷六月久久综合丁香| 91麻豆精品激情在线观看国产| 露出奶头的视频| 午夜精品久久久久久毛片777| 九色国产91popny在线| 欧美 亚洲 国产 日韩一| 国产三级在线视频| 天堂动漫精品| 大香蕉久久成人网| 亚洲情色 制服丝袜| 欧美成人午夜精品| 国产蜜桃级精品一区二区三区| 高清黄色对白视频在线免费看| 国产区一区二久久| 久久久久久久久中文| 不卡一级毛片| 欧美老熟妇乱子伦牲交| 69av精品久久久久久| 欧美黄色淫秽网站| 好看av亚洲va欧美ⅴa在| 亚洲 国产 在线| 岛国视频午夜一区免费看| 电影成人av| 亚洲avbb在线观看| 欧美精品啪啪一区二区三区| 纯流量卡能插随身wifi吗| 99国产精品免费福利视频| 欧美色视频一区免费| 黄片播放在线免费| 色哟哟哟哟哟哟| 中文字幕人妻丝袜一区二区| 亚洲五月婷婷丁香| 国产人伦9x9x在线观看| 女同久久另类99精品国产91| 精品人妻在线不人妻| 久久亚洲真实| 国产精品 欧美亚洲| 又紧又爽又黄一区二区| 免费av毛片视频| 国产成人影院久久av| 正在播放国产对白刺激| 侵犯人妻中文字幕一二三四区| 欧美激情 高清一区二区三区| 欧美乱妇无乱码| 成人18禁在线播放| 麻豆成人av在线观看| 亚洲第一欧美日韩一区二区三区| 国产99久久九九免费精品| 好看av亚洲va欧美ⅴa在| 日韩成人在线观看一区二区三区| 久久久久久大精品| 三级毛片av免费| 亚洲专区字幕在线| 美女大奶头视频| 欧美成人一区二区免费高清观看 | 99精品久久久久人妻精品| 欧美一级a爱片免费观看看 | 一区二区三区精品91| 国产在线精品亚洲第一网站| 国产视频一区二区在线看| 欧美日本亚洲视频在线播放| 国产91精品成人一区二区三区| 黄色视频,在线免费观看| 1024视频免费在线观看| 制服人妻中文乱码| 免费在线观看影片大全网站| 人人妻人人爽人人添夜夜欢视频| 给我免费播放毛片高清在线观看| 欧美久久黑人一区二区| 久久婷婷成人综合色麻豆| 亚洲av成人av| bbb黄色大片| 成人永久免费在线观看视频| 日韩 欧美 亚洲 中文字幕| 中亚洲国语对白在线视频| 国产人伦9x9x在线观看| 亚洲国产高清在线一区二区三 | 九色亚洲精品在线播放| 国产免费av片在线观看野外av| 一边摸一边抽搐一进一小说| 91老司机精品| 欧美+亚洲+日韩+国产| 国产精品爽爽va在线观看网站 | 狠狠狠狠99中文字幕| 国产激情久久老熟女| 日本黄色视频三级网站网址| 老汉色av国产亚洲站长工具| 18禁黄网站禁片午夜丰满| 欧美绝顶高潮抽搐喷水| 男女做爰动态图高潮gif福利片 | 国产精品永久免费网站| 亚洲五月色婷婷综合| 美女高潮喷水抽搐中文字幕| a在线观看视频网站| 啦啦啦观看免费观看视频高清 | 99riav亚洲国产免费| 窝窝影院91人妻| 久久人人精品亚洲av| 久久久久久久久久久久大奶| 亚洲天堂国产精品一区在线| 身体一侧抽搐| 美女高潮到喷水免费观看| 女人精品久久久久毛片| 手机成人av网站| 国产成年人精品一区二区| 可以在线观看的亚洲视频| 国产伦一二天堂av在线观看| 精品国产美女av久久久久小说| 18禁黄网站禁片午夜丰满| 免费在线观看视频国产中文字幕亚洲| 久久精品国产亚洲av香蕉五月| 国产欧美日韩一区二区精品| 香蕉久久夜色| 国产主播在线观看一区二区| 欧美成狂野欧美在线观看| 色综合婷婷激情| 在线观看免费视频网站a站| cao死你这个sao货| 人人澡人人妻人| 亚洲少妇的诱惑av| 亚洲国产欧美一区二区综合| 黄色a级毛片大全视频| 村上凉子中文字幕在线| 最近最新免费中文字幕在线| 99久久99久久久精品蜜桃| 久热这里只有精品99| 久久久久久大精品| 老司机午夜福利在线观看视频| 久久香蕉精品热| 亚洲性夜色夜夜综合| 高清在线国产一区| 神马国产精品三级电影在线观看 | 狂野欧美激情性xxxx| 久久久久久免费高清国产稀缺| 日韩三级视频一区二区三区| 麻豆av在线久日| 国产激情欧美一区二区| 每晚都被弄得嗷嗷叫到高潮| 久久中文看片网| 在线av久久热| 老司机靠b影院| 天天添夜夜摸| 日本三级黄在线观看| 亚洲成人久久性| 精品国产乱码久久久久久男人| 国产精品久久电影中文字幕| 亚洲一区二区三区色噜噜| 久久香蕉国产精品| 中文字幕色久视频| 成人特级黄色片久久久久久久| 免费高清在线观看日韩| 国产精品二区激情视频| 法律面前人人平等表现在哪些方面| 女人被躁到高潮嗷嗷叫费观| 一级,二级,三级黄色视频| 亚洲中文日韩欧美视频| 91字幕亚洲| 精品不卡国产一区二区三区| 久久欧美精品欧美久久欧美| 99国产综合亚洲精品| 国产亚洲欧美精品永久| 免费在线观看影片大全网站| 免费女性裸体啪啪无遮挡网站| 国产av一区在线观看免费| 国产精品久久久久久亚洲av鲁大| 99riav亚洲国产免费| 无限看片的www在线观看| 日韩欧美三级三区| 国产亚洲欧美98| 少妇 在线观看| 免费高清在线观看日韩| 国产av一区在线观看免费| 亚洲少妇的诱惑av| 男人的好看免费观看在线视频 | 国产精品亚洲一级av第二区| 欧美日韩亚洲综合一区二区三区_| 黄色丝袜av网址大全| 韩国精品一区二区三区| 最近最新免费中文字幕在线| 香蕉国产在线看| 国产成人一区二区三区免费视频网站| 亚洲自偷自拍图片 自拍| 精品乱码久久久久久99久播| 中文字幕色久视频| 女人被躁到高潮嗷嗷叫费观| av网站免费在线观看视频| 精品高清国产在线一区| 丰满的人妻完整版| 女警被强在线播放| 国产视频一区二区在线看| 国产av精品麻豆| 亚洲欧美日韩高清在线视频| 美女午夜性视频免费| 18禁黄网站禁片午夜丰满| 在线观看免费视频日本深夜| 国产精品av久久久久免费| 国产人伦9x9x在线观看| 久久国产乱子伦精品免费另类| 国产精华一区二区三区| 亚洲专区字幕在线| www.999成人在线观看| 日韩欧美在线二视频| 男女午夜视频在线观看| 69精品国产乱码久久久| 黄网站色视频无遮挡免费观看| 搡老妇女老女人老熟妇| 99精品在免费线老司机午夜| 免费av毛片视频| 成年女人毛片免费观看观看9| 亚洲 国产 在线| 成人手机av| 9热在线视频观看99| 国产精品av久久久久免费| 欧美一级a爱片免费观看看 | 亚洲第一欧美日韩一区二区三区| 丝袜在线中文字幕| 视频在线观看一区二区三区| 亚洲最大成人中文| 免费高清在线观看日韩| 日韩大尺度精品在线看网址 | 欧美日韩亚洲国产一区二区在线观看| 涩涩av久久男人的天堂| 国产欧美日韩一区二区精品| 一级a爱视频在线免费观看| 天天添夜夜摸| 国产99久久九九免费精品| 久久精品国产清高在天天线| 国产精品亚洲av一区麻豆| 亚洲全国av大片| 大香蕉久久成人网| 老熟妇乱子伦视频在线观看| 免费看美女性在线毛片视频| 91精品国产国语对白视频| 欧美老熟妇乱子伦牲交| 亚洲avbb在线观看| 亚洲美女黄片视频| 很黄的视频免费| 身体一侧抽搐| 国产成人影院久久av| 国产精品一区二区精品视频观看| 91av网站免费观看| 看黄色毛片网站| 老汉色av国产亚洲站长工具| 国产aⅴ精品一区二区三区波| 精品国产一区二区三区四区第35| 国产亚洲欧美98| 乱人伦中国视频| 男人操女人黄网站| 亚洲人成网站在线播放欧美日韩| av网站免费在线观看视频| 又黄又爽又免费观看的视频| 国产av精品麻豆| 午夜日韩欧美国产| 国产黄a三级三级三级人| 两个人看的免费小视频| 一a级毛片在线观看| www国产在线视频色| 一区二区三区激情视频| videosex国产| 一级毛片精品| 一二三四社区在线视频社区8| 久久影院123| 亚洲视频免费观看视频| 国产单亲对白刺激| 日本五十路高清| 国产麻豆成人av免费视频| 欧美一区二区精品小视频在线| 国产av又大| 不卡一级毛片| 中国美女看黄片| 97人妻天天添夜夜摸| 叶爱在线成人免费视频播放| 搡老熟女国产l中国老女人| 亚洲中文av在线| 窝窝影院91人妻| 天堂√8在线中文| 欧美一级a爱片免费观看看 | 亚洲情色 制服丝袜| 亚洲成人国产一区在线观看| 伦理电影免费视频| 亚洲视频免费观看视频| 级片在线观看| 国产精品久久久久久精品电影 | 免费久久久久久久精品成人欧美视频| 欧美av亚洲av综合av国产av| 老司机午夜福利在线观看视频| 91成人精品电影| 国产精品亚洲av一区麻豆| 国产成人系列免费观看| 国产精品亚洲av一区麻豆| 久久久国产欧美日韩av| e午夜精品久久久久久久| 国产男靠女视频免费网站| 黄色片一级片一级黄色片| 嫩草影视91久久| 黄色片一级片一级黄色片| 每晚都被弄得嗷嗷叫到高潮| 男人操女人黄网站| 亚洲成人久久性| 又大又爽又粗| 亚洲国产日韩欧美精品在线观看 | 97人妻天天添夜夜摸| 一级,二级,三级黄色视频| 一级黄色大片毛片| 国产成人影院久久av| 一区二区三区激情视频| 中文字幕另类日韩欧美亚洲嫩草| 老司机福利观看| 日本黄色视频三级网站网址| 国产欧美日韩精品亚洲av| bbb黄色大片| 香蕉久久夜色| 日本 av在线| 91国产中文字幕| 一级毛片高清免费大全| 欧美日本亚洲视频在线播放| cao死你这个sao货| 国产精品野战在线观看| 精品人妻在线不人妻| 国产极品粉嫩免费观看在线| 悠悠久久av| 99在线视频只有这里精品首页| 欧美一区二区精品小视频在线| 国产麻豆69| 欧美av亚洲av综合av国产av| 欧美日韩亚洲国产一区二区在线观看| 精品人妻在线不人妻| 亚洲情色 制服丝袜| 黄色视频不卡| 丝袜美足系列| 精品免费久久久久久久清纯| 国产乱人伦免费视频| 欧美成人一区二区免费高清观看 | av天堂在线播放| 成年女人毛片免费观看观看9| 在线观看一区二区三区| 日本在线视频免费播放| 亚洲av美国av| 精品一区二区三区av网在线观看| 亚洲中文av在线| 亚洲一区二区三区不卡视频| 久久久久久久精品吃奶| 精品少妇一区二区三区视频日本电影| 午夜精品在线福利| 午夜福利高清视频| 操美女的视频在线观看| 美女免费视频网站| 精品久久久久久成人av| 久久中文看片网| 99国产精品99久久久久| 免费看美女性在线毛片视频| 老司机在亚洲福利影院| 一边摸一边抽搐一进一小说| 每晚都被弄得嗷嗷叫到高潮| aaaaa片日本免费|